JP2008509950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509950A5 JP2008509950A5 JP2007526351A JP2007526351A JP2008509950A5 JP 2008509950 A5 JP2008509950 A5 JP 2008509950A5 JP 2007526351 A JP2007526351 A JP 2007526351A JP 2007526351 A JP2007526351 A JP 2007526351A JP 2008509950 A5 JP2008509950 A5 JP 2008509950A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- dioxo
- imidazolidin
- thiazol
- butyramide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60217504P | 2004-08-17 | 2004-08-17 | |
| US60/602,175 | 2004-08-17 | ||
| US68299705P | 2005-05-20 | 2005-05-20 | |
| US60/682,997 | 2005-05-20 | ||
| PCT/EP2005/008633 WO2006018188A2 (en) | 2004-08-17 | 2005-08-09 | Substituted hydantoins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008509950A JP2008509950A (ja) | 2008-04-03 |
| JP2008509950A5 true JP2008509950A5 (https=) | 2012-01-05 |
| JP4927733B2 JP4927733B2 (ja) | 2012-05-09 |
Family
ID=35589619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526351A Expired - Fee Related JP4927733B2 (ja) | 2004-08-17 | 2005-08-09 | 置換ヒダントイン |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7427635B2 (https=) |
| EP (1) | EP1781649B1 (https=) |
| JP (1) | JP4927733B2 (https=) |
| KR (2) | KR20090006885A (https=) |
| AR (1) | AR050297A1 (https=) |
| AT (1) | ATE404556T1 (https=) |
| AU (1) | AU2005274390B2 (https=) |
| BR (1) | BRPI0514515A (https=) |
| CA (1) | CA2576599A1 (https=) |
| DE (1) | DE602005008986D1 (https=) |
| ES (1) | ES2313389T3 (https=) |
| MX (1) | MX2007001846A (https=) |
| PL (1) | PL1781649T3 (https=) |
| RU (1) | RU2383542C2 (https=) |
| TW (1) | TW200621764A (https=) |
| WO (1) | WO2006018188A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200621766A (en) * | 2004-09-17 | 2006-07-01 | Hoffmann La Roche | Substituted hydantoins |
| US7612212B2 (en) | 2006-02-22 | 2009-11-03 | Hoffmann-La Roche Inc. | Substituted hydantoins |
| CN101702878B (zh) * | 2007-05-11 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 可溶性差的药物的药物组合物 |
| MX2010001581A (es) | 2007-08-16 | 2010-03-15 | Hoffmann La Roche | Hidantoinas substituidas. |
| US8063085B2 (en) | 2007-12-20 | 2011-11-22 | Hoffmann-La Roche Inc. | Substituted hydantoins |
| US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
| US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| AU2009330686B2 (en) * | 2008-06-16 | 2014-07-03 | The Ohio State University Research Foundation | Compounds for the treatment of cancer |
| US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| EP2370568B1 (en) | 2008-12-10 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Mek mutations conferring resistance to mek inhibitors |
| WO2011000945A2 (en) * | 2009-07-03 | 2011-01-06 | Nensius Research A/S | Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| EP3028699B1 (en) | 2010-02-25 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Braf mutations conferring resistance to braf inhibitors |
| MX2012010115A (es) | 2010-03-01 | 2013-02-26 | Gtx Inc | Compuestos para el tratamiento de cancer. |
| CN103038364A (zh) | 2010-03-09 | 2013-04-10 | 达纳－法伯癌症研究所公司 | 诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法 |
| BR112012027762B1 (pt) | 2010-04-28 | 2018-06-05 | Bayer Intellectual Property Gmbh | Derivados de cetoheteroarilpiperidina e - piperazina como fungicidas |
| US20150141470A1 (en) | 2012-05-08 | 2015-05-21 | The Broad Institute, Inc. | Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy |
| US12110299B2 (en) * | 2018-09-17 | 2024-10-08 | Yungjin Pharm. Co., Ltd. | Thiazole derivatives and pharmaceutically acceptable salts thereof |
| WO2021182914A1 (ko) * | 2020-03-13 | 2021-09-16 | 영진약품 주식회사 | 신규한 cdk7 억제 화합물 및 이의 약제학적으로 허용가능한 염 |
| US20230095520A1 (en) * | 2020-03-13 | 2023-03-30 | Yungjin Pharm. Co., Ltd. | Pharmaceutical composition for preventing or treating cancer comprising azole derivatives or pharmaceutically acceptable salt thereof |
| KR20210146144A (ko) | 2020-05-26 | 2021-12-03 | 엘지전자 주식회사 | 카트부 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| NZ501276A (en) | 1997-07-01 | 2000-10-27 | Warner Lambert Co | 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders |
| AU2001252270B2 (en) * | 2000-05-03 | 2005-12-15 | F. Hoffmann-La Roche Ag | Hydantoin-containing glucokinase activators |
| ATE345341T1 (de) * | 2001-07-19 | 2006-12-15 | Pfizer Italia Srl | Phenylacetamido-thiazole verbindungen, verfahren zu ihren herstellung und ihre anwendung als antitumor mittel |
-
2005
- 2005-08-09 AT AT05771890T patent/ATE404556T1/de active
- 2005-08-09 RU RU2007109651/04A patent/RU2383542C2/ru not_active IP Right Cessation
- 2005-08-09 JP JP2007526351A patent/JP4927733B2/ja not_active Expired - Fee Related
- 2005-08-09 PL PL05771890T patent/PL1781649T3/pl unknown
- 2005-08-09 WO PCT/EP2005/008633 patent/WO2006018188A2/en not_active Ceased
- 2005-08-09 CA CA002576599A patent/CA2576599A1/en not_active Abandoned
- 2005-08-09 KR KR1020087032084A patent/KR20090006885A/ko not_active Ceased
- 2005-08-09 KR KR1020077004075A patent/KR100889721B1/ko not_active Expired - Fee Related
- 2005-08-09 AU AU2005274390A patent/AU2005274390B2/en not_active Ceased
- 2005-08-09 BR BRPI0514515-5A patent/BRPI0514515A/pt not_active IP Right Cessation
- 2005-08-09 MX MX2007001846A patent/MX2007001846A/es active IP Right Grant
- 2005-08-09 DE DE602005008986T patent/DE602005008986D1/de not_active Expired - Lifetime
- 2005-08-09 EP EP05771890A patent/EP1781649B1/en not_active Expired - Lifetime
- 2005-08-09 ES ES05771890T patent/ES2313389T3/es not_active Expired - Lifetime
- 2005-08-11 US US11/202,299 patent/US7427635B2/en not_active Expired - Fee Related
- 2005-08-15 TW TW094127672A patent/TW200621764A/zh unknown
- 2005-08-16 AR ARP050103440A patent/AR050297A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008509950A5 (https=) | ||
| JP5675773B2 (ja) | Ｃｃｒ２の４−アゼチジニル−１−フェニル−シクロヘキサンアンタゴニスト | |
| ES2240558T3 (es) | Derivados de tiazol y oxazol como activadores de receptores activados por el proliferador de peroxisoma humano. | |
| JP5244863B2 (ja) | ジオキサン−２−アルキルカルバメート誘導体の製造法およびその中間体 | |
| RU2383542C2 (ru) | Замещенные гидантоины | |
| RU2007116317A (ru) | Гексафторизопропанол-замещенные производные простых эфиров | |
| JP2018531982A5 (https=) | ||
| JP2009508963A5 (https=) | ||
| JP2009538333A5 (https=) | ||
| JP2007519692A5 (https=) | ||
| JP4796046B2 (ja) | ピペリジニルアルキルカーバメートの誘導体、これらの製造方法及びｆａａｈ酵素インヒビターとしての使用 | |
| JP2007511485A5 (https=) | ||
| JP2006506380A5 (https=) | ||
| AU2010236336B2 (en) | 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2 | |
| JP2010504323A5 (https=) | ||
| JP2004507501A5 (https=) | ||
| KR101972619B1 (ko) | 페닐 유도체 | |
| CA2598516A1 (en) | Benzisoxazole derivatives | |
| JP2008540595A5 (https=) | ||
| JPWO2021007663A5 (https=) | ||
| JP2006509022A5 (https=) | ||
| US8440819B2 (en) | Therapeutic substituted beta-lactams | |
| RU2006102866A (ru) | Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar | |
| JP2007532576A5 (https=) | ||
| JP2002167371A (ja) | フェニルプロピオン酸誘導体 |